Trial intelligence / Profile preview

Validation of the Eleveld remimazolam PK/PD model

NL-OMON61304Not yet recruiting

Sponsor
University Medical Center Groningen
Start
Nov 2026
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of remimazolam in anaesthesia, sponsored by University Medical Center Groningen. Primary endpoints: Performance error, Median performance error and 6 more. Planned start Nov 2026; status: not yet recruiting.

02

Drugs

remimazolam
03

Conditions

anaesthesia

Beyond the preview

Go deeper on NL-OMON61304.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON61304.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call